Question 1

What is Unicycive Therapeutics?

Accepted Answer

Unicycive Therapeutics is a Company.

Question 2

How often does Unicycive Therapeutics appear in global news?

Accepted Answer

Tracked across 3 news events drawn from 18 articles.

Question 3

When was Unicycive Therapeutics first tracked by NewsDesk?

Accepted Answer

First tracked on Aug 21, 2025.

Question 4

When was Unicycive Therapeutics last mentioned in news?

Accepted Answer

Last active on Apr 16, 2026.

Question 5

What is Unicycive Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: -63 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Unicycive Therapeutics in global news coverage?

Accepted Answer

Attention score of 2, derived from article volume and coverage intensity across 3 events.

Question 7

What is the most recent event involving Unicycive Therapeutics?

Accepted Answer

Unicycive Therapeutics Faces Securities Lawsuit (Aug 22, 2025, 6 articles).

Question 8

Who is Unicycive Therapeutics most connected to?

Accepted Answer

Top relationships: United States — Food and Drug Administration, United States — Food and Drug Administration.

Question 9

How did the "Unicycive Therapeutics Faces Securities Lawsuit" event impact Unicycive Therapeutics?

Accepted Answer

Unicycive Therapeutics is facing a federal securities class action lawsuit due to allegedly making false and misleading statements regarding its manufacturing compliance and regulatory prospects for OLC NDA, which led to significant stock price drops.

Question 10

How did the "Unicycive Therapeutics faces securities lawsuit" event impact Unicycive Therapeutics?

Accepted Answer

Unicycive Therapeutics is being sued for allegedly issuing materially false and/or misleading statements regarding its readiness to satisfy FDA manufacturing compliance requirements and the regulatory prospects of its oxylanthanum carbonate new drug application.

Question 11

How did the "Unicycive Therapeutics faces class action" event impact Unicycive Therapeutics?

Accepted Answer

Unicycive Therapeutics is the defendant in a class action lawsuit alleging false and misleading statements regarding its manufacturing compliance and regulatory prospects for oxylanthanum carbunate (OLC). This event negatively impacts Unicycive Therapeutics's reputation and stock price.

Question 12

How is this data collected?

Accepted Answer

NewsDesk aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.